Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
This has been the focus of his research and lectures his entire career
Retatrutide Phase 2 Obesity Trial: Efficacy and Safety at 48 Weeks New England Journal of Medicine Phase 2 trial in 338 adults with obesity showed retatrutide 12 mg produced 24.2% body weight loss at 48 weeks the highest reported for any anti-obesity pharmacotherapy with manageable GI side effects
Food cue reactivity consequently leads to a series of outcomes, some of which are short-term, while others are long-term
Reduced calorie intake may contribute to fat loss over time
US$ 23.70
US$ 25.24
US$ 22.75
US$ 27.21
